Team:Aachen/Parts
From 2014.igem.org
(→characterization of K1319001 with the iGEM Team Aachen 2D Biosensor) |
(→iGEM Team Aachen Biobrick overview) |
||
(3 intermediate revisions not shown) | |||
Line 19: | Line 19: | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319003 K1319003] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319003 K1319003] | ||
+ | ||human galectin-3, codon optimized for ''E. coli'' | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319004 K1319004] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319004 K1319004] | ||
+ | ||TEV protease with anti-self cleavage mutation S219V, codon optimized for ''E. coli'' | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319008 K1319008] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319008 K1319008] | ||
+ | ||IPTG-induced and T7-driven expression of TEV protease | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319009 K1319009] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319009 K1319009] | ||
+ | ||mRFP-galectin3-his fusion protein CDS | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319010 K1319010] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319010 K1319010] | ||
+ | ||Constitutive expression of K1319000 | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319011 K1319011] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319011 K1319011] | ||
+ | ||Constitutive expression of K1319001 | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319012 K1319012] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319012 K1319012] | ||
+ | ||Constitutive expression of K1319002 | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319013 K1319013] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319013 K1319013] | ||
+ | ||Constitutive expression of GFP-REACh1 fusion protein | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319014 K1319014] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319014 K1319014] | ||
+ | ||Constitutive expression of GFP-REACh2 fusion protein | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319015 K1319015] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319015 K1319015] | ||
+ | ||Constitutive expression of GFP-EYFP fusion protein | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319016 K1319016] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319016 K1319016] | ||
+ | ||TEV protease cleavage site | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319017 K1319017] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319017 K1319017] | ||
+ | ||LasI induced iLOV | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319020 K1319020] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319020 K1319020] | ||
+ | ||Translational unit of mRFP-galectin3-his | ||
|- | |- | ||
| [https://2014.igem.org/Team:Aachen/Parts#partsK1319042 K1319042] | | [https://2014.igem.org/Team:Aachen/Parts#partsK1319042 K1319042] | ||
+ | ||IPTG inducible iLOV | ||
|} </center> | |} </center> | ||
Line 255: | Line 269: | ||
<span class="anchor" id="partsK1319003"></span> | <span class="anchor" id="partsK1319003"></span> | ||
- | === | + | ===Human galectin-3, codon-optimized for ''E. coli''=== |
Galectin-3 is a 26 kDa protein that binds certain LPS patterns. It especially bind the O-section of the LPS. | Galectin-3 is a 26 kDa protein that binds certain LPS patterns. It especially bind the O-section of the LPS. | ||
Line 264: | Line 278: | ||
Human galectin-3 is a protein of the lectin-family that was shown to bind the LPS of multiple human pathogens. | Human galectin-3 is a protein of the lectin-family that was shown to bind the LPS of multiple human pathogens. | ||
- | Some of them, including ''Pseudomonas aeruginosa'' protect themselves against the human immune system by mimicking the lipopolysaccharides (LPS) present on human erythrocytes. | + | Some of them, including ''Pseudomonas aeruginosa'' protect themselves against the human immune system by mimicking the lipopolysaccharides (LPS) present on human erythrocytes. |
===Usage and Biology=== | ===Usage and Biology=== | ||
Line 295: | Line 309: | ||
<span class="anchor" id="partsK1319004"></span> | <span class="anchor" id="partsK1319004"></span> | ||
- | ===TEV protease with anti-self cleavage mutation S219V, codon optimized for ''E. coli''=== | + | ===TEV protease with anti-self cleavage mutation S219V, codon-optimized for ''E. coli''=== |
This part is a TEV protease in RFC25 that was optimized for expression in E. coli. The part contains the S219V anti-self cleavage mutation. | This part is a TEV protease in RFC25 that was optimized for expression in E. coli. The part contains the S219V anti-self cleavage mutation. | ||
Line 486: | Line 500: | ||
===iGEM Team Aachen Biobrick overview=== | ===iGEM Team Aachen Biobrick overview=== | ||
+ | |||
<groupparts>iGEM14 Aachen</groupparts> | <groupparts>iGEM14 Aachen</groupparts> | ||
{{Team:Aachen/Footer}} | {{Team:Aachen/Footer}} |
Latest revision as of 03:38, 18 October 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|